Discover opportunities months before the RFP drops
Learn more →Retrieving RFP details
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
The purpose of MOOR's Buprenorphine Training Grant Program is to distribute funding to the highest-scoring proposals received from county governments to support the costs of training paramedics in buprenorphine administration. Emergency medical services (EMS) personnel are often the first responders to overdoses and, as such, are in the best position to administer naloxone. After receiving naloxone, someone who is physically dependent on opioids will experience withdrawal. Buprenorphine is a medication that reduces withdrawal symptoms, giving survivors of opioid overdose a chance to seek treatment and recovery services through their family, friends, and community partnerships.
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Provide training program.
Posted Date
Jan 8, 2026
Due Date
Apr 30, 2026
Release: Jan 8, 2026
Close: Apr 30, 2026
Provide training program.
AvailableProvide Buprenorphine HCL/Nalaxone HCL Tablets. Description Size Estimated Annual Requirements (Bottle) BuprenorphineHCL 2mg/Naloxone HCL 0.5mg Tab, Sublingual 30 171,239 BuprenorphineHCL 8mg/Naloxone HCL 2mg Tab, Sublingual 30 251,144.
Posted Date
Dec 31, 2025
Due Date
Jan 19, 2026
Release: Dec 31, 2025
Close: Jan 19, 2026
Provide Buprenorphine HCL/Nalaxone HCL Tablets. Description Size Estimated Annual Requirements (Bottle) BuprenorphineHCL 2mg/Naloxone HCL 0.5mg Tab, Sublingual 30 171,239 BuprenorphineHCL 8mg/Naloxone HCL 2mg Tab, Sublingual 30 251,144.
AvailableSeeking proposals for an Academic Coaching Training Program.
Posted Date
Jan 5, 2026
Due Date
Jan 16, 2026
Release: Jan 5, 2026
Close: Jan 16, 2026
Seeking proposals for an Academic Coaching Training Program.
AvailableSeasonal Communities Grant Program (SCGP)
Posted Date
Dec 10, 2025
Due Date
Jan 10, 2026
Release: Dec 10, 2025
Close: Jan 10, 2026
Seasonal Communities Grant Program (SCGP)
AvailableSurface intent from meeting minutes, budgets, and contract expirations. Influence RFP requirements before competitors ever see them.
See your top 10 upcoming opportunities on a demo →Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis